122 related articles for article (PubMed ID: 16183464)
1. The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Litwin AH; Clements BJ; Gourevitch MN
J Subst Abuse Treat; 2005 Oct; 29(3):159-65. PubMed ID: 16183464
[TBL] [Abstract][Full Text] [Related]
2. Treating hepatitis C virus infection in active substance users.
Sylvestre DL
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
[TBL] [Abstract][Full Text] [Related]
3. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Clements BJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):741-7. PubMed ID: 17700258
[TBL] [Abstract][Full Text] [Related]
4. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
Litwin AH; Soloway I; Gourevitch MN
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
[TBL] [Abstract][Full Text] [Related]
5. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.
Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B
Drug Alcohol Depend; 2008 Jan; 93(1-2):141-7. PubMed ID: 17997050
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
Day C; Ross J; Dolan K
Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital.
Scheft H; Fontenette DC
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
9. Experience of hepatitis C among current or former heroin users attending general practice.
Cullen W; Kelly Y; Stanley J; Langton D; Bury G
Ir Med J; 2005 Mar; 98(3):73-4. PubMed ID: 15869062
[TBL] [Abstract][Full Text] [Related]
10. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
11. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
12. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
Doab A; Treloar C; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
[TBL] [Abstract][Full Text] [Related]
13. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
14. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
Cohen-Moreno R; Schiff M; Levitt S; Bar-Hamburger R; Strauss S; Neumark Y
Subst Use Misuse; 2010; 45(1-2):58-76. PubMed ID: 20025439
[TBL] [Abstract][Full Text] [Related]
15. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
Bloor M; McIntosh J; McKeganey N; Robertson M
Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
[TBL] [Abstract][Full Text] [Related]
18. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of HCV in a cohort of injectors on methadone substitution treatment.
Lee KC; Lim WW; Lee SS
J Clin Virol; 2008 Apr; 41(4):297-300. PubMed ID: 18191614
[TBL] [Abstract][Full Text] [Related]
20. Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in israel.
Peles E; Rados V; Adelson M
Subst Use Misuse; 2007; 42(9):1477-84. PubMed ID: 17886143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
